What is NDC 0173-0873?

0173-0873 is the product NDC for Incruse Ellipta (umeclidinium), Umeclidinium bromide 62.5 ug/1 aerosol, powder, listed with the FDA by GlaxoSmithKline LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Incruse Ellipta (Umeclidinium).

GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Incruse Ellipta?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Incruse Ellipta NDC 0173-0873 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0173-0873Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00173-0873Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0173-0873-06	0017308730600173087306	1 TRAY in 1 CARTON (0173-0873-06) / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALERMarketed from Apr 30, 2014
0173-0873-10	0017308731000173087310	1 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALERMarketed from Apr 30, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Incruse Ellipta
Generic name (nonproprietary): umeclidinium
Active ingredients: Umeclidinium bromide — 62.5 ug/1
Dosage form: Aerosol, Powder
Route: Oral
Labeler: GlaxoSmithKline LLCNDC labeler code 0173
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 205382
Marketing start: Apr 30, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 0173-0873_4049ca45-7739-4d4a-bcce-50c5b3c7415fSPL ID 4049ca45-7739-4d4a-bcce-50c5b3c7415fSPL set ID dbb64747-1505-49d7-9a33-99dd402e96d3RxCUI 1539251, 1539885, 1596444, 1596445UNII 7AN603V4JV
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400173087306 followed by a unit qualifier and the quantity

Package 00173-0873-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 13, 2023.

Indications (excerpt from the label)

INCRUSE ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). INCRUSE ELLIPTA is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0173-0873

What is NDC 0173-0873?: 0173-0873 is the product NDC for Incruse Ellipta (umeclidinium), Umeclidinium bromide 62.5 ug/1 aerosol, powder, listed with the FDA by GlaxoSmithKline LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Incruse Ellipta (Umeclidinium).
What is the active ingredient?: Umeclidinium bromide.
Who is the labeler?: GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Incruse Ellipta?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 205382

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 205382
Product	Strength	Form · route	Labeler	Product NDC
Umeclidinium Elliptaumeclidinium	Umeclidinium bromide 62.5 ug/1	Aerosol, PowderOral	Prasco Laboratories	66993-189

Incruse Ellipta (Umeclidinium) NDC 0173-0873